In the context of providing correct and accurate information to the public, the Ministry of Health is organizing a press conference on Monday 17 January 2022, at 11:15 am."Administration of the antiviral drug Molnupiravir (Lagevrio) in Cyprus".
The conference will be addressed by the Minister of Health Mr. Michalis Hadjipandela. Subsequently, the Deputy Director of Pharmaceutical Services, Ms. Elena Panagiotopoulou, will inform the representatives of the media about the procedure to be followed regarding the administration of the drug to patients.
Attendees will be required to present a SafePass.
(AF)
Contents of this article including associated images are owned by PIO
Views & opinions expressed are those of the author and/or PIO
Source
